Latest filing published 10 Jan 2023 for Novocure Ltd, €5,803.
Filing timeline
BuySaleInsider track record
Ely Benaim: trading record in brief
Ely Benaim has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Novocure Ltd and Opus Genetics, Inc. In total, 47 filings cover trades dated from 28 February 2018 to 6 January 2023.
Sales make up the whole of the open-market record (26 sales, €4.9M). Besides market trades, the filings include 9 share grants and 12 option exercises.
On 10 January 2023 came the latest disclosure, a share grant for €5,803 in Novocure Ltd. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Ely Benaim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 98 shares@ US$62.3050.8% of flowOrdinary SharesSEC:0001645113-23-000012:0
- 5,396 shares@ US$74.006.5% of flowOrdinary SharesSEC:0001645113-22-000073:1
- 563 shares@ US$71.095.1% of flowOrdinary SharesSEC:0001645113-22-000073:0
- 437 shares@ US$69.6593.9% of flowOrdinary SharesSEC:0001645113-22-000070:0
- 222 shares@ US$59.0751.7% of flowOrdinary SharesSEC:0001645113-22-000061:0
- 2,135 shares@ US$61.252.1% of flowOrdinary SharesSEC:0001645113-22-000046:1
- 2,070 shares@ US$65.15816.7% of flowOrdinary SharesSEC:0001645113-22-000046:0
- 803 shares@ US$74.500.9% of flowOrdinary SharesSEC:0001645113-22-000017:1
- 1,510 shares@ US$70.411.6% of flowOrdinary SharesSEC:0001645113-22-000017:2
- 17,371 shares0Ordinary SharesSEC:0001645113-22-000017:0
- 55 shares@ US$63.8180.4% of flowOrdinary SharesSEC:0001645113-22-000006:0
- 464 shares@ US$150.117.6% of flowOrdinary SharesSEC:0001645113-21-000095:0
- 651 shares@ US$158.961.6% of flowOrdinary SharesSEC:0001645113-21-000094:1
- 536 shares@ US$149.381.3% of flowOrdinary SharesSEC:0001645113-21-000094:2
- 651 shares@ US$83.305.9% of flowOrdinary SharesSEC:0001645113-21-000094:0
- 90 shares@ US$137.1221.4% of flowOrdinary SharesSEC:0001645113-21-000085:0
- 1,833 shares@ US$200.005.6% of flowOrdinary SharesSEC:0001645113-21-000069:1
- 1,833 shares@ US$47.569.3% of flowOrdinary SharesSEC:0001645113-21-000069:0
- 1,943 shares@ US$180.4837.8% of flowOrdinary SharesSEC:0001645113-21-000068:0
- 1,833 shares@ US$189.655.4% of flowOrdinary SharesSEC:0001645113-21-000067:1
- 2,262 shares@ US$180.126.3% of flowOrdinary SharesSEC:0001645113-21-000067:2
- 1,833 shares@ US$47.569.4% of flowOrdinary SharesSEC:0001645113-21-000067:0
- 1,833 shares@ US$47.561.4% of flowOrdinary SharesSEC:0001645113-21-000053:0
- 1,833 shares@ US$200.005.7% of flowOrdinary SharesSEC:0001645113-21-000053:1
- 651 shares@ US$83.300.8% of flowOrdinary SharesSEC:0001645113-21-000053:2
25 of 47 declarations
